Navigation Links
United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
Date:7/28/2011

ative expenses for the quarter ended June 30, 2011, compared to the same quarter in 2010, corresponded principally to increases in professional fees in connection with various completed and prospective transactions, and travel expenses, as a result of our growth and increase in business development activities.

Sales and marketing. The increase in sales and marketing expenses for the quarter ended June 30, 2011, compared to the quarter ended June 30, 2010, was attributable to an increase in salaries, as we recently expanded our sales force, and an increase in professional fees in connection with our marketing and advertising initiatives.

Share-based compensation. The decrease in share-based compensation for the quarter ended June 30, 2011, compared to the same quarter in 2010, reflects a reduction in share-based compensation recognized in connection with our share tracking awards plans as a result of the decrease in our stock price.

2011 Revenue GuidanceWe reaffirm our full-year revenue guidance for our three commercial products (Remodulin, Tyvaso and Adcirca), and we continue to expect related revenues to fall within a range of 5% above or below $750 million for 2011.

Earnings Before Non-Cash ChargesEarnings before non-cash charges is defined as net income, adjusted for the following non-cash charges, as applicable: (1) interest; (2) income taxes; (3) license fees; (4) depreciation and amortization; (5) impairment charges; and (6) share-based compensation (stock option and share tracking award expense).

A reconciliation of net income to earnings before non-cash charges is presented below (in thousands, except per share data):Three Months EndedJune 30,20112010Net income, as reported

$

73,891$

37,707Adjust for non-cash charges:Interest expense

5,4314,759Income tax expense

35,72319,212License fees

——Depreciation and amortization

4,8374,582Impairment cha
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. FDA Advisory Panel Unanimously Recommends Approval of EXCOR(R) Pediatric Ventricular Assist Device for Use in the United States
2. Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom
3. United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011
4. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
5. United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
6. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2010 Financial Results Before Market Open on Tuesday, February 15, 2011
7. United Therapeutics Corporation Reports Third Quarter 2010 Financial Results
8. United Therapeutics Corporation to Announce Third Quarter 2010 Financial Results Before Market Open on Thursday, October 28, 2010
9. Sangart, Inc. Receives $1.1 Million Grant Award from the United States Department of Defense for Further Development of MP4 Molecule in Trauma
10. United Therapeutics Corporation to Announce Second Quarter 2010 Financial Results Before Market Open on Wednesday, July 28, 2010
11. Report Details How States Respond to Citizens United Decision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)...  AMRI (NASDAQ: AMRI ) announced ... , site has received approval to expand its ... handle Schedule 2 and 2N controlled substances. The ... Burlington,s physical security and quality systems, ... http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) With its ...
(Date:6/18/2013)... , June 18, 2013 Mapi Pharma ... generic and innovative intermediates, and finished dosage forms based on ... been granted a United States patent ... Europe for the oral treatment of moderate-to-severe ... titled Intermediate Compounds and Processes for the Preparation of ...
(Date:6/18/2013)... 2013 This webinar will examine ... and promotion, and review the basic FDA regulations ... to apply these principles through real world case ...     The fundamentals on FDA regulations and guidance related ...     Assessing traditional and newer forms of promotional ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/4b8vj2/injectable_drug ) has announced the addition of ... Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables ... Free & Auto Injectors] & Therapeutics [Diabetes ... report to their offering. ...
Breaking Biology Technology:AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3
... ,,,,, PfuTurbo DNA ... Pfx DNA polymerase , Michael ... recently evaluated the properties of Platinum ,Pfx DNA ... polymerase and polymerase-specific antibodies. Comparisons,revealed that Stratagenes PfuTurbo ...
... cDNA Library Array I ,, Over 145,000 human cDNA clones arrayed for nucleic ... Jean-Michel Llias Leonardo de Leon Bruce Jerpseth , ... Stratagene , Stratagene has organized over ... cDNA library that represent genes expressed in 29 different human tissues. , ...
... cloning kits feature new additions , Tim Sanchez ... kits are convenient for cloning,PCR fragments generated ... easy, and superior to other available methods. 3 Now,Stratagene ... , PCR purification kit, so preparing PCR products is ...
Cached Biology Technology:Comparing Fidelity and Performance of Proofreading PCR Enzymes 2Comparing Fidelity and Performance of Proofreading PCR Enzymes 3Comparing Fidelity and Performance of Proofreading PCR Enzymes 4Comparing Fidelity and Performance of Proofreading PCR Enzymes 5Comparing Fidelity and Performance of Proofreading PCR Enzymes 6Comparing Fidelity and Performance of Proofreading PCR Enzymes 7Comparing Fidelity and Performance of Proofreading PCR Enzymes 8Human Universal cDNA Library Array I 2Human Universal cDNA Library Array I 3Human Universal cDNA Library Array I 4Human Universal cDNA Library Array I 5Human Universal cDNA Library Array I 6Human Universal cDNA Library Array I 7Enhanced PCR Cloning System 2Enhanced PCR Cloning System 3Enhanced PCR Cloning System 4
(Date:6/17/2013)... MANHATTAN, KAN. -- A Kansas State University research associate ... on mosquitoes and ways to prevent the spread of ... received the National Institutes of Health,s National Research Service ... years. He is the seventh Kansas State University researcher ... on campus to currently hold such an award. , ...
(Date:6/17/2013)... method of mining shale gas, is widespread across Pennsylvania, ... New research in the Annals of the New ... to biodiversity including pollution from toxic chemicals, the building ... , "Shale gas has engendered a great deal of ... but effects on biological diversity and resources have scarcely ...
(Date:6/16/2013)... A mechanism that cells use to group together and move ... been described for the first time by scientists at UCL. ... new study focuses on the process that occurs when cancer ... the body during metastasis. Scientists know that cancer cells recruit ... how this process takes place and how it could be ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2'Chase and run' cell movement mechanism explains process of metastasis 2
... realizing that the potential for bioterrorism isn,t just about ... introduction of bacteria, a virus or a toxin could ... issuing a paper aimed at prevention. "Any emerging ... trade needs to be aware of the potential for ...
... an elusive gene responsible for Gray Platelet Syndrome, an extremely ... have been reported. As a result, it is hoped that ... test. The findings were made following a collaborative study ... both based at the Wellcome Trust Sanger Institute and the ...
... do a herd of gazelles and a fluffy mass ... describes the population dynamics of such prey animals as ... the relationship between cloud systems, rain and tiny floating ... understand, among other things, how human-produced aerosols affect rainfall ...
Cached Biology News:Global bioterrorism threat analyzed for world animal health office 2Anglo-French team discover elusive gene that makes platelets gray 2Anglo-French team discover elusive gene that makes platelets gray 3Anglo-French team discover elusive gene that makes platelets gray 4Eat, prey, rain 2
STX18 Immunogen: STX18 (NP_058626, 101 a.a. ~ 200 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
Request Info...
Anti-Bcl-G (CT) Host: rabbit polyclonal Species Reactivity: human, mouse, rat Applications: WB, IHC Storage: 4C...
Biology Products: